Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.

Panebianco F, Mazzanti C, Tomei S, Aretini P, Franceschi S, Lessi F, Di Coscio G, Bevilacqua G, Marchetti I.

BMC Cancer. 2015 Nov 19;15:918. doi: 10.1186/s12885-015-1917-2.

2.

Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.

Colato C, Vicentini C, Cantara S, Pedron S, Brazzarola P, Marchetti I, Di Coscio G, Chilosi M, Brunelli M, Pacini F, Ferdeghini M.

Eur J Endocrinol. 2015 May;172(5):571-82. doi: 10.1530/EJE-14-0930. Epub 2015 Feb 19.

3.

BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency.

Agretti P, Niccolai F, Rago T, De Marco G, Molinaro A, Scutari M, Di Cosmo C, Di Coscio G, Vitale M, Maccheroni M, Vitti P, Tonacchera M.

J Endocrinol Invest. 2014 Oct;37(10):1009-14. doi: 10.1007/s40618-014-0166-6. Epub 2014 Sep 7.

PMID:
25194426
4.

Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas.

Proietti A, Borrelli N, Giannini R, Romani R, Di Coscio G, Quilici F, Rago T, Miccoli P, Vitti P, Basolo F.

Cancer Cytopathol. 2014 Oct;122(10):751-9. doi: 10.1002/cncy.21454. Epub 2014 Jun 9.

5.

Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one.

Ciregia F, Giusti L, Molinaro A, Niccolai F, Agretti P, Rago T, Di Coscio G, Vitti P, Basolo F, Iacconi P, Tonacchera M, Lucacchini A.

PLoS One. 2013 Sep 2;8(9):e72911. doi: 10.1371/journal.pone.0072911. eCollection 2013.

6.

Are risk factors common to thyroid cancer and nodule? A forty years observational time-trend study.

Carpi A, Rossi G, Romani R, Di Coscio G, Nicolini A, Simoncini T, Russo M, Mechanick J.

PLoS One. 2012;7(10):e47758. doi: 10.1371/journal.pone.0047758. Epub 2012 Oct 31.

7.

A molecular computational model improves the preoperative diagnosis of thyroid nodules.

Tomei S, Marchetti I, Zavaglia K, Lessi F, Apollo A, Aretini P, Di Coscio G, Bevilacqua G, Mazzanti C.

BMC Cancer. 2012 Sep 7;12:396. doi: 10.1186/1471-2407-12-396.

8.

MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.

Agretti P, Ferrarini E, Rago T, Candelieri A, De Marco G, Dimida A, Niccolai F, Molinaro A, Di Coscio G, Pinchera A, Vitti P, Tonacchera M.

Eur J Endocrinol. 2012 Sep;167(3):393-400. doi: 10.1530/EJE-12-0400. Epub 2012 Jun 22.

9.

c-KIT receptor expression is strictly associated with the biological behaviour of thyroid nodules.

Tomei S, Mazzanti C, Marchetti I, Rossi L, Zavaglia K, Lessi F, Apollo A, Aretini P, Di Coscio G, Bevilacqua G.

J Transl Med. 2012 Jan 10;10:7. doi: 10.1186/1479-5876-10-7.

10.

Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.

Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G.

Thyroid. 2012 Mar;22(3):292-8. doi: 10.1089/thy.2011.0107. Epub 2011 Dec 19.

PMID:
22181337
11.

Large needle aspiration biopsy histology for preoperative selection of Hürthle cell thyroid nodules.

Carpi A, Rossi G, Mechanick JI, Nicolini A, Camici M, Russo MA, Di Coscio G.

Histopathology. 2011 Nov;59(5):892-6. doi: 10.1111/j.1365-2559.2011.04014.x.

PMID:
22092401
12.

Genetic markers to discriminate benign and malignant thyroid nodules with undetermined cytology in an area of borderline iodine deficiency.

Tonacchera M, Agretti P, Rago T, De Marco G, Niccolai F, Molinaro A, Scutari M, Candelieri A, Conforti D, Musmanno R, Di Coscio G, Basolo F, Iacconi P, Miccoli P, Pinchera A, Vitti P.

J Endocrinol Invest. 2012 Sep;35(8):754-9. Epub 2011 Oct 4.

PMID:
21979329
13.

Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine.

Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P.

Endocr Relat Cancer. 2011 Jul 1;18(4):429-37. doi: 10.1530/ERC-11-002. Print 2011 Aug.

14.

BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features.

Proietti A, Giannini R, Ugolini C, Miccoli M, Fontanini G, Di Coscio G, Romani R, Berti P, Miccoli P, Basolo F.

Thyroid. 2010 Nov;20(11):1263-70. doi: 10.1089/thy.2009.0283. Epub 2010 Oct 17.

PMID:
20950194
15.

Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology.

Rago T, Scutari M, Santini F, Loiacono V, Piaggi P, Di Coscio G, Basolo F, Berti P, Pinchera A, Vitti P.

J Clin Endocrinol Metab. 2010 Dec;95(12):5274-80. doi: 10.1210/jc.2010-0901. Epub 2010 Sep 1.

PMID:
20810572
16.

L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.

Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Miccoli P, Grasso L, Pinchera A, Vitti P.

Endocr Relat Cancer. 2010 Feb 18;17(1):231-9. doi: 10.1677/ERC-09-0251. Print 2010 Mar.

17.

Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question.

Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A.

J Clin Endocrinol Metab. 2010 Apr;95(4):1516-27. doi: 10.1210/jc.2009-1536. Epub 2010 Feb 15.

PMID:
20156922
18.

Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease.

Rago T, Fiore E, Scutari M, Santini F, Di Coscio G, Romani R, Piaggi P, Ugolini C, Basolo F, Miccoli P, Pinchera A, Vitti P.

Eur J Endocrinol. 2010 Apr;162(4):763-70. doi: 10.1530/EJE-09-0895. Epub 2010 Jan 18.

19.

Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases.

Fiore E, Rago T, Scutari M, Ugolini C, Proietti A, Di Coscio G, Provenzale MA, Berti P, Grasso L, Mariotti S, Pinchera A, Vitti P.

J Endocrinol Invest. 2009 Apr;32(4):344-51.

PMID:
19636204
20.

Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.

Fiore E, Rago T, Provenzale MA, Scutari M, Ugolini C, Basolo F, Di Coscio G, Berti P, Grasso L, Elisei R, Pinchera A, Vitti P.

Endocr Relat Cancer. 2009 Dec;16(4):1251-60. doi: 10.1677/ERC-09-0036. Epub 2009 Jun 15.

Supplemental Content

Loading ...
Support Center